On May 22, 2024, Assure Holdings Corp., a Nevada-based company listed on the NASDAQ Capital Market under the trading symbol IONM, filed a Form 8-K with the United States Securities and Exchange Commission (SEC). The report announced a corporate update call held by Assure and Danam Health, Inc. on the same day. The presentation from the call was filed as Exhibit 99.1 and incorporated by reference. The report also mentioned that Assure has filed a registration statement on Form S-4 with the SEC on May 3, 2024, which includes a prospectus and a proxy statement regarding a proposed transaction between Assure and Danam Health Inc. The proxy statement/prospectus will be mailed to the stockholders of both companies, and the transaction is pending SEC...Show More

On May 22, 2024, Assure Holdings Corp., a Nevada-based company listed on the NASDAQ Capital Market under the trading symbol IONM, filed a Form 8-K with the United States Securities and Exchange Commission (SEC). The report announced a corporate update call held by Assure and Danam Health, Inc. on the same day. The presentation from the call was filed as Exhibit 99.1 and incorporated by reference. The report also mentioned that Assure has filed a registration statement on Form S-4 with the SEC on May 3, 2024, which includes a prospectus and a proxy statement regarding a proposed transaction between Assure and Danam Health Inc. The proxy statement/prospectus will be mailed to the stockholders of both companies, and the transaction is pending SEC approval and stockholder consent. Assure and Danam Health Inc. are in the process of soliciting proxies from Assure's stockholders in connection with the proposed transaction. The report contains forward-looking statements about the proposed transaction, including the structure, timing, and completion of the merger, the listing of the combined company on Nasdaq, and the anticipated ownership structure post-merger. The document also outlines the risks and uncertainties associated with the proposed transaction, such as the possibility of not obtaining the necessary stockholder approval or failing to meet other closing conditions.